Innovation Task Force (ITF) briefing meetings provide developers an opportunity to engage in an early dialogue on innovative medicines with EMA.
The meetings assist developers in deciding on the next steps in their development programmes.
They complement existing formal EMA procedures and target all types of developers. These developers include:
The meetings address regulatory, technical and scientific concerns arising from innovative medicines, technologies and methodologies.
Taking place earlier in the development process than scientific advice, they facilitate informal exchanges of information and guidance.
The meetings are free-of-charge and held virtually. They provide special support in the following areas:
An overview timeline of the application process is available below.
Find detailed information, and the documents necessary to apply, in the 'Documents' section on this page.
Step 1: Request form
Complete the ITF briefing meeting request form and send it via Eudralink or e-mail it to:
ITFSecretariat@ema.europa.eu (human)
ITFvet@ema.europa.eu (veterinary)
Step 2: Briefing document
EMA may ask applicant to complete and send a briefing document
Step 3: EMA review
EMA reviews within 1-3 weeks the information received and suggests an option best suited to applicant's needs (i.e. granting of meeting or referral to other procedure(s))
Step 4: Register in IRIS
If a meeting is granted, the applicant registers in IRIS and requests the creation of a research product identifier (RPI)